gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Heart Defects, Congenital in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Wakeel-Marquard, N; Berger, F; Kuehne, T; Messroghli, DR; Muench, F; O H-Ici, D; Rastin, S; Yilmaz, S | 1 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Heart Defects, Congenital
Article | Year |
---|---|
Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.
Topics: Adolescent; Adult; Case-Control Studies; Contrast Media; Female; Fibrosis; Heart Defects, Congenital; Heart Ventricles; Heterocyclic Compounds; Humans; Infusions, Parenteral; Injections; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Young Adult | 2017 |